^
BIOMARKER:
EGFR T790M
i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR T790M
NSCLC
osimertinib
Sensitive
:
A1
EGFR T790M
NSCLC
lazertinib
Sensitive
:
A1
EGFR T790M
NSCLC
almonertinib
Sensitive
:
A1
EGFR T790M
LUAD
erlotinib
Sensitive
:
B
EGFR T790M
NSCLC
afatinib
Sensitive
:
B
EGFR T790M
NSCLC
erlotinib + ramucirumab
Sensitive
:
B
EGFR T790M
LUAD
gefitinib
Sensitive
:
B
EGFR T790M
NSCLC
bevacizumab
Sensitive
:
B
EGFR T790M
LUAD
osimertinib
Resistant
:
C1
EGFR T790M
NSCLC
bevacizumab + osimertinib
Sensitive
:
C2
EGFR T790M
NSCLC
rociletinib
Sensitive
:
C2
EGFR T790M
NSCLC
ASP8273
Sensitive
:
C2
EGFR T790M
NSCLC
ASK120067
Sensitive
:
C2
EGFR T790M
NSCLC
osimertinib + ramucirumab
Sensitive
:
C2
EGFR T790M
NSCLC
olmutinib
Sensitive
:
C2
EGFR T790M
NSCLC
osimertinib + ABT 263
Sensitive
:
C2
EGFR T790M
NSCLC
lazertinib
Sensitive
:
C2
EGFR T790M
NSCLC
anlotinib
Sensitive
:
C2
EGFR T790M
NSCLC
AST2818
Sensitive
:
C2
EGFR T790M
NSCLC
AC0010MA
Sensitive
:
C2
EGFR T790M
NSCLC
D-0316
Sensitive
:
C2
EGFR T790M
Lung Non-Squamous Non-Small Cell Cancer
PD-L1 inhibitor
Resistant
:
C3
EGFR T790M
NSCLC
EGFR inhibitor
Resistant
:
C3
EGFR T790M
LUAD
bevacizumab + osimertinib
Resistant
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our